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Summary
Purpose: To determine the acute change in cardiac performance after intravenous
immunoglobulin infusion (IVIG) in patients with acute Kawasaki disease (KD).
Materials and methods: Subjects were 33 patients with KD who were treated with
IVIG 2 g/kg and recovered without coronary artery lesion and 27 controls. Subjects
underwent combined two-dimensional, Doppler, and tissue Doppler echocardio-
graphic (TDI) studies. In KD, these echocardiographic studies were performed before
IVIG, 48 h after IVIG, and in convalescence. Echocardiographic variables were com-
pared between KD and controls as well as among 3 time points in KD.
Results: Before IVIG, KD showed signiﬁcantly higher peak aortic velocity and
shorter aortic ejection time as results of tachycardia and signiﬁcantly lower
E′ (p < 0.04) but signiﬁcantly higher E/E′ (p < 0.02). After IVIG, patients with
KD became afebrile and showed signiﬁcantly lower TDI indices such as S′, E′,
and, A′ and isovolumic acceleration (IVA) (163± 56 vs. 208± 70 cm/s2, p < 0.01)
with higher TDI-derived Tei index (0.50± 0.10 vs. 0.44± 0.06, p < 0.02) than
controls. These differences tended to disappear in convalescence. In analy-
sis of repeated measurements, except for hemodynamic changes associated
with tachycardia, S′ (7.9± 1.3 vs. 7.0± 1.1 vs. 7.4± 0.9 cm/s, p < 0.001), IVA
(227± 72 vs. 163± 56 vs. 180± 63, p < 0.05), and A′ (7.7± 3.0 vs. 5.6± 1.3 vs.
6.7± 2.3 cm/s, p < 0.001) were signiﬁcantly different among these time points.
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Conclusions: In patients with acute KD with usual course, IVIG induced transient sub-
clinical longitudinal left ventricular dysfunction.
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Introduction
Kawasaki disease (KD) is a systemic vasculi-
tis affecting small- to medium-sized vessels and
myocardium and is the most frequent acquired
heart disease in developed countries [1,2]. About
one quarter of patients with KD show transient dila-
tion of proximal coronary arteries [3] and only a
small number of patients suffer real myocardial dys-
function, myocarditis [4]. However, there has been
little information concerning the change in left ven-
tricular performance after high-dose intravenous
immunoglobulin infusion (IVIG) in patients without
overt myocardial dysfunction.
Historically Newburger et al. [5] and Moran
et al. [6] reported that circumferential systolic
left ventricular function is depressed with respect
to given stress, expressed by end-systolic wall
stress, before treatment but improves after IVIG
with clinical response. These studies were based
on classic M-mode echocardiography and may
be affected by geometrical changes, as occurs
with pulmonary hypertension. On the other hand,
recently introduced sophisticated tissue Doppler
echocardiography allows us to evaluate longitudi-
nal left ventricular function. Using tissue Doppler
echocardiography, Takeuchi et al. [7] reported that
longitudinal systolic function, evaluated by peak
systolic annular velocity (S′), may not improve but
be latently depressed after IVIG in a subgroup
of patients with acute KD who initially showed
lower type B natriuretic peptide (BNP) <51 pg/ml.
However, even S′ is thought to be load-dependent
and isovolumic acceleration (IVA) is proposed as a
new load-independent index of longitudinal systolic
ventricular function derived from tissue Doppler
echocardiography [8,9]. Therefore, the purpose of
this study was to further elucidate the change in
longitudinal left ventricular function after high-
dose IVIG in patients with acute KD who respond to
a single dose of IVIG using tissue Doppler echocar-
diography incorporating IVA.Materials and methods
Subjects were 33 patients (19 boys and 14 girls)
with KD (KDG) who fulﬁlled the diagnostic crite-
ria of KD and 27 controls (12 boys and 15 girls)
a
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iCardiology. Published by Elsevier Ireland Ltd. All rights
ith comparable age. All patients with KD were
uccessfully treated with IVIG 2 g/kg, in a single
nfusion over 24 h, and with 30mg/kg of aspirin
nitially and 5mg/kg of aspirin after resolution of
ever at Kurume University Hospital. IVIG was given
t a mean of 5.0± 1.1 days of illness and no patient
equired additional treatment such as a second
ose of IVIG or pulse steroid infusion. Mean serum
-reactive protein before IVIG was 8.8± 4.7mg/dl.
o patient required any cardiotonic drug to sup-
ort ventricular function. Of 33 patients, 3 (9%)
howed transient dilation of coronary artery with
ore than +2.5 SD in diameter, but no patient left
ith coronary artery aneurysms at convalescence.
chocardiography
GE VIVID 7 cardiac ultrasound system (GE,
orten, Norway) was used for the imaging, and
mages were stored digitally for off-line analysis
sing the GE EchoPac analysis software (GE). In
wo-dimensional echocardiography, left ventricu-
ar end-diastolic dimension (ZLVDd) and coronary
rtery diameter converted to Z-score based on
ody surface area and ejection fraction (EF) were
etermined. In Doppler echocardiography, peak
ortic velocity (AV), peak mitral E and A wave
elocity, E/A ratio, aortic pre-ejection period (D-
EP), aortic ejection time (D-ET), D-PEP/ET, and
ei index (D-Tei) were determined [10,11]. Like-
ise, in tissue Doppler echocardiography, annular
nterventricular peak systolic velocity (S′), early
iastolic velocity (E′), and late diastolic veloc-
ty (A′), aortic pre-ejection period (T-PEP), aortic
jection time (T-ET), T-PEP/ET, and Tei index (T-
ei) [12] were determined. IVA was measured at
he mitral annulus and in the basal interventric-
lar septum and was measured as the slope of
he pre-systolic velocity curve expressed in cm/s2
8,9]. In addition, rate corrected mean velocity of
ircumferential ﬁber shortening (mVcfc) was cal-
ulated from known formula [5]. These studies
ere performed before IVIG (mean± standard devi-fter IVIG (9.6± 1.7 days of illness), and more than
weeks (29.9± 5.3 days of illness) after IVIG. Each
ariable was compared between KDG and controls
t 3 time points as well as among 3 time points
n KDG.
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Table 1 Impact of intravenous immunoglobulin infusion on longitudinal left ventricular performance in patients
with acute Kawasaki disease.
Control Pre-IVGG Post-IVGG Convalescence
DOI (days) 5.3 ± 1.4 9.6 ± 1.7 29.9 ± 5.3
Age (years) 3.0 ± 2.0 2.7 ± 2.1
Heart rate (bpm) 109 ± 25 139 ± 24a 98 ± 16a,b 108 ± 17b
Ejection fraction (%) 71 ± 7 69 ± 8 71 ± 8 72 ± 7
Z-LVDd 0.8 ± 0.9 0.8 ± 1.7 1.0 ± 1.6 0.7 ± 1.6
mVcfc 1.07 ± 0.19 1.10 ± 0.24 1.07 ± 0.26 1.06 ± 0.17
IVA (cm/s2) 208 ± 70 227 ± 72 163 ± 56a,b 180 ± 63b
S′ wave (cm/s) 7.8 ± 1.3 7.9 ± 1.3 7.0 ± 1.1a,b 7.4 ± 0.9a
E′ wave (cm/s) 12.3 ± 2.4 11.1 ± 2.2a 10.5 ± 2.0a,b 11.2 ± 1.9
A′ wave (cm/s) 6.7 ± 2.5 7.7 ± 3.0 5.6 ± 1.3a,b 6.7 ± 2.3
E′/A′ 2.0 ± 0.6 1.6 ± 0.7a 2.0 ± 0.6 1.8 ± 0.6
E/E′ 8.7 ± 1.9 10.1 ± 2.1a 10.1 ± 2.2a 9.2 ± 1.7
T-PEP (ms) 53 ± 11 48 ± 11 63 ± 12a,b 62 ± 15a,b
T-ET (ms) 234 ± 30 191 ± 26a 244 ± 25b 229 ± 16b
T-IRT (ms) 50 ± 10 41 ± 9a 59 ± 12a,b 50 ± 7b,c
T-PEP/ET 0.23 ± 0.04 0.25 ± 0.05 0.26 ± 0.06a 0.27 ± 0.06a
T-Tei 0.44 ± 0.06 0.47 ± 0.08 0.50 ± 0.10a 0.49 ± 0.08a
Peak AV (cm/s) 92 ± 23 114 ± 22a 98 ± 19b 90 ± 18b
D-PEP (ms) 48 ± 11 47 ± 8 56 ± 12a,b 56 ± 10a,b
D-ET (ms) 243 ± 30 199 ± 26a 254 ± 29b 241 ± 24b
D-PEP/ET 0.20 ± 0.05 0.24 ± 0.04a 0.22 ± 0.04 0.23 ± 0.04a
D-E wave (cm/s) 103 ± 12 110 ± 14 105 ± 16 101 ± 17
D-A wave (cm/s) 61 ± 18 69 ± 19 56 ± 12 62 ± 18
D-E/A 1.8 ± 0.5 1.7 ± 0.6 1.9 ± 0.5 1.8 ± 0.5
D-Tei 0.31 ± 0.07 0.28 ± 0.08 0.32 ± 0.07 0.31 ± 0.08
Abbreviations: D: variables measured by Doppler method; T: those measured by Tissue Doppler method; A′ wave: peak late diastolic
velocity of annular interventricular septum; AoET: aortic ejection time; DOI: days of illness; E′ wave: peak early diastolic velocity
of annular interventricular septum; IRT: iso-volumic relaxation time; IVA: iso-volumic acceleration; Tei: Tei index; mVcfc: rate
corrected mean velocity of circumferential ﬁber shortening; PEP: pre-ejection period; S′ wave: peak systolic velocity of annular
interventricular septum; post-IVGG: after intravenous gamma globulin infusion; pre-IVGG: before intravenous gamma globulin
infusion.
a p < 0.05 vs. control.
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ntra- and inter-observer variability
ntra- and inter-observer (KS and HN) variability was
valuated for all tissue Doppler derived variables
ncluding IVA in 20 randomly selected recordings.
ariability was determined as a mean percent error
erived from the absolute difference between two
bservations divided by the mean of the two obser-
ations.
In addition, we measured BNP before IVIG in all
atients except for one in whom we could not get
ample available for analysis.tatistical analysis
ariables are expressed as mean and standard devi-
tions. Comparison between KDG and controls was
ade using unpaired t-test and differences in con-
B
f
v
Aecutive changes of echocardiographic parameters
mong 3 time points were determined by one way
NOVA with post-hoc analysis using Tukey method.
orrelations between BNP and echocardiographic
arameters were determined using Peason’s cor-
elation coefﬁcient. Level of statistical difference
as set at p < 0.05. All data analyses were per-
ormed by a commercially available statistical
nalysis software package (Statview 5.0, SAS Insti-
ute Inc., Cary, NC, USA and SPSS 8.0, SPSS Inc.,
hicago, IL, USA).
esultsefore IVIG treatment, patients with KD suffered
rom high fever and showed tachycardia (139± 23
s. 109± 25 bpm, p < 0.001) leading to higher peak
V (114± 22 vs. 92± 23 cm/s, p < 0.001), but
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Figure 1 (A) Change in isovolumic acceleration after
intravenous immunoglobulin. Isovolumic acceleration
decreased signiﬁcantly after intravenous immunoglobu-
lin infusion from baseline, was signiﬁcantly lower than
controls, and gradually recovered in convalescence.
(B) Change in peak systolic velocity of annular inter-
ventricular septum after intravenous immunoglobulin.
Peak systolic velocity of annular interventricular septum
derived from tissue Doppler echocardiography decreased
signiﬁcantly after intravenous immunoglobulin infusion
from baseline that was signiﬁcantly lower than control
and gradually recovered in convalescence. IVA: isovo-
lumic acceleration; post-IVIG: value after intravenous
i
v
o48
shorter ETs (D-ET, 199± 26 vs. 243± 30; T-ET,
191± 26 vs. 234± 30ms, p < 0.001, respectively)
(Table 1). Left ventricular function was well
preserved and there was no signiﬁcant differ-
ence in S′ (7.9± 1.3 vs. 7.8± 1.3 cm/s), IVA
(227± 72 vs. 208± 70 cm/s2), and Tei index (D-Tei,
0.28± 0.08 vs. 0.31± 0.07 and T-Tei, 0.47± 0.08
vs. 0.44± 0.06) between KDG and controls.
However, after IVIG treatment, left ventricular
longitudinal systolic function was transiently but
signiﬁcantly compromised as reﬂected by signiﬁ-
cantly decreased IVA 163± 56 vs. 227± 72 cm/s2,
p < 0.001) and S′ (7.0± 1.1 vs. 7.9± 1.3 cm/s,
p < 0.001) from baseline that were signiﬁcantly
lower than controls (Fig. 1). In parallel with
these changes, PEPs prolonged (D-PEP, 56± 12 vs.
47± 8ms; T-PEP, 63± 12 vs. 48± 11ms, p < 0.001,
respectively) and PEP/ET, T-Tei, T-IRT, and E/E′
increased signiﬁcantly, but E′ and A′ decreased
signiﬁcantly. This longitudinal left ventricular dys-
function improved with time, but some variables
stayed in abnormal range even in convalescence.
Of note, any echocardiographic variables based
on two-dimensional echocardiography, such as
ejection fraction, left ventricular end-diastolic
dimension, or mVcfc did not change signiﬁcantly.
Mean and standard deviation of BNP was 61± 90
(2—441) pg/ml and 24 of 32 (75%) patients showed
BNP <51 pg/ml. BNP signiﬁcantly positively corre-
lated with T-Tei (r = 0.44, p < 0.02) as well as EF
(r = 0.51, p < 0.003) before IVIG, but did not corre-
late with any of the echocardiographic parameters
after IVIG.
Intra- and inter-observer variability
Intra-observer variability for S′, E′, A′, T-PEP, T-ET,
T-IRT, IVA were 0.1± 1.4%, 0.2± 1.1%, 0.5± 1.1%,
0.3± 1.9%, 0± 0.3%, 0.2± 1.4%, and 4.3± 4.1%,
respectively. Inter-observer variability for S′, E′, A′,
T-PEP, T-ET, T-IRT, IVA were 0.5± 3.3%, 1.4± 3.5%,
1.9± 2.1%, 5.3± 6.4%, 0.6± 0.7%, 2.4± 4.0%, and
4.0± 5.3%, respectively. The percentage differ-
ences in intra- and inter-observer variability were
not signiﬁcant.
Discussion
This study indicates that high-dose IVIG infusion can
induce sub-clinical transient longitudinal left ven-
tricular dysfunction in patients with acute KD of
usual course.
In this study, we have shown that tissue Doppler
derived S′ and IVA decreased and tissue Doppler
d
i
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l
tmmunoglobulin infusion; pre-IVIG: value before intra-
enous immunoglobulin infusion; S′: peak systolic velocity
f annular interventricular septum.
erived Tei index and PEP/ET as well as E/E′
ncreased after IVIG and these changes gradually
ormalized with time. Because IVA is known to be a
oad-independent index of systolic ventricular func-
ion and Tei index is also known to be relatively
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oad-independent index, this left ventricular sys-
olic dysfunction after IVIG should be real. These
esults are compatible with the report by Takeuchi
t al. [7] that showed apparently two distinct pat-
erns of left ventricular performance after IVIG. In
heir report, patients were divided into two groups
ccording to the initial level of BNP, patients with
NP 51 pg/ml and those with BNP <51 pg/ml, and
he patients with BNP <51 pg/ml showed sustained
ecrease in S′ after IVIG. In this study, the major-
ty (75%) of the patients had BNP <51 pg/ml before
VIG and showed decrease in S′ and IVA although
here was no signiﬁcant difference in echocardio-
raphic parameters after IVIG between the two
roups because the number of patients with BNP
51 pg/ml was too small.
The discrepancy between D-Tei and T-Tei may
eed some explanations. Although we showed rel-
tively higher T-Tei in controls [13], this value
0.44± 0.06) is comparable with published nor-
al values by Harada et al. (0.41± 0.06) [14] for
hildren. In addition, Gaibazzi et al. reported a
igniﬁcant difference between T-Tei and D-Tei in
ontrols (0.42± 0.09 vs. 0.33± 0.09) as well as in
atients with congestive heart failure (0.79± 0.12
s. 0.69± 0.15), although these were in adults [15].
herefore, even if we have a certain tendency in
easuring T-Tei, the observed trend per se can be
ccepted as long as we applied consistent method
eveloped in our laboratory with a uniform leading
nd tailing edges techniques [16].
Furthermore, recent accumulating data from
nimal models and human study suggest that T-
ei may be more accurate in evaluating global
eft ventricular performance than D-Tei; T-Tei was
losely correlated with left ventricular ﬁlling pres-
ure in a dog model with acute volume challenge
17], showed better correlation with ejection frac-
ion and had better reproducibility than D-Tei in
mouse model with myocardial infarction [18],
as less pre-load-dependent and was more accu-
ate in assessing global left ventricular function in
atients on hemodialysis [19]. Therefore it is possi-
le that, in concert with the change in S′ and IVA,
-Tei reﬂected a small but signiﬁcant change in left
entricular performance after IVIG that could not
e appreciated by D-Tei.
On the other hand, these results may look incon-
istent with some other studies. Newburger et al.
5] and Moran et al. [6] reported rapid improvement
n left ventricular performance after IVIG. However,
oth studies had different administration protocols
f IVIG (400mg/kg for 4 days vs. 2 g/kg over 24 h),
xamined left ventricular performance at different
ime points (10 days, 11—31 days, and 1—3 months;
re-treatment, day 1, 2, 3, and 2—6 weeks vs. pre-
w
n
o
h
m49
reatment and 48 h after treatment in our study),
nd used different echocardiographic method from
ur study. Especially they applied stress—velocity
elationship expressed by mVcfc with respect to
iven stress and this method can be potentially
ompromised by geometrical change and measures
nly circumferential left ventricular function. In
ontrast to them, we applied tissue Doppler method
nd measured longitudinal function of left ventri-
le and time intervals independent of geometrical
hanges. Therefore, it is possible that patients
ith KD suffer from longitudinal left ventricu-
ar dysfunction with preserved or compensatory
ncreased circumferential or radial function after
VIG.
Also, this longitudinal left ventricular dysfunc-
ion may be associated with diastolic dysfunction.
n this study, not only S′ or IVA decreased, but also
′ as well as A′ decreased and IRT increased after
VIG (Table 1). Compatible with these ﬁndings, Yu et
l. recently reported that index of left ventricular
ass is elevated even after IVIG and is associated
ith diastolic dysfunction in patients with acute KD
20].
linical implications
eft ventricular longitudinal dysfunction with pre-
erved radial function are believed to precede overt
ardiac failure and have been observed increas-
ngly in many asymptomatic patients with cardiac
iseases such as moderate to severe aortic regur-
itation [21], diabetic heart disease [22], and
ortic stenosis [23]. Therefore, this sub-clinical left
entricular longitudinal dysfunction must be impor-
ant when we treat patients with KD who fail to
espond to 1st treatment because additional high-
ose IVIG treatment may further aggravate volume
verload and increase viscosity [24], although it
hould decrease circulating cytokines and allevi-
te myocardial inﬂammation [25,26] and recently
ntroduced tumor necrosis factor antagonist, inﬂix-
mab [27], was reported to have harmful effect on
ardiac function [28]. Further studies to determine
echanisms and clinical importance of this tran-
ient left ventricular longitudinal dysfunction are
equired.
tudy limitations
his is a case—control study comparing patients
ith KD and healthy controls; however, we did
ot have the opportunity to examine patients with
ther febrile or afebrile disease who received
igh-dose IVIG using combined echocardiographic
ethods and could not determine that this is the
[[
[
[
[
[
[
[
[
[
[
[50
unique ﬁnding in patients with KD after IVIG. Also,
we no longer give IVIG as 400mg/kg for 4—5 days
instead of 2 g/kg over 24 h and we could not deter-
mine the effect of treatment protocol of IVIG on left
ventricular performance. Although this study might
have enrolled a relatively small number of patients,
the decreases in S′ and IVA were very obvious and
may not be affected by an increasing number of
subjects.
In conclusion, IVIG improves clinical conditions
but may induce transient sub-clinical longitudinal
left ventricular dysfunction despite well preserved
circumferential left ventricular function in patients
with acute KD with usual course. In cases of
IVIG resistance, this may need to be taken into
account to prevent cardiac function from further
deterioration leading to overt cardiac failure. The
mechanisms and clinical signiﬁcance of this tran-
sient sub-clinical ventricular dysfunction must be
explored.
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